Your trusted source for investing success

Tag: Cannabinoid

Isodiol International Inc. Signs Binding Supply Agreement with Namaste Technologies Inc.

Isodiol International Inc. Signs Binding Supply Agreement with Namaste Technologies Inc.

Isodiol International Inc. (CSE: ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bio-active phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a binding agreement with Namaste Technologies Inc. (“Namaste”) (CNSX:N) (OTCQB:NXTTF) (FRA:M5BQ), an online retailer for cannabis delivery

Isodiol International Inc. Announces Letter of Intent to Import 99%+ Pure Pharma-Grade Cannabidiol to Canada From U.K. With Nuuvera

Isodiol International Inc. Announces Letter of Intent to Import 99%+ Pure Pharma-Grade Cannabidiol to Canada From U.K. With Nuuvera

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has signed a letter of intent (LOI) with Nuuvera Holdings Limited (TSXV:NUU), a global cannabis company founded on Canadian principles,

Phivida Signs Brand Licensing Agreement in Oregon

Phivida Signs Brand Licensing Agreement in Oregon

Phivida Holdings Inc. (CSE:VIDA) is proud to announce that it has entered into a brand licensing agreement with Nova Paths, LLC (“Nova Paths”) to license Phivida’s proprietary cannabidiol (“CBD”) infused functional foods, beverages and clinical formulas.

Phivida Unaffected by Rescinded Cole Memorandum

Phivida Unaffected by Rescinded Cole Memorandum

Phivida Holdings Inc. (“Phivida” or the “Company” traded as (“CSE:VIDA, OTCMKTS: PHVAF”) announced today that it is confident that the hemp industry would be unaffected by the US Attorney General’s recent reversal of the Cole Memorandum.

Harvest One Announces Retail Platform and Branding Strategy

Harvest One Announces Retail Platform and Branding Strategy

Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company”) through its wholly owned subsidiary United Greeneries (“United Greeneries” or “UG”) is pleased to announce the launch of retail sales beginning February 2018;
Retail sales to commence February 2018
Over 325 kg of dried cannabis currently in stock for immediate sale
Initial import license

2017 Wrap-Up by Lexaria’s CEO

2017 Wrap-Up by Lexaria’s CEO

Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”) announces it’s been quite an amazing year for Lexaria stakeholders – the busiest and most productive we’ve had. I’ve welcomed so many new shareholders and Lexaria fans in 2017 and I want to ensure both our new followers as well as our

Isodiol International Inc. Signs Licensing Agreement with Level Brands Inc. and Its Chairman Emeritus And Chief Brand Strategist Kathy Ireland

Isodiol International Inc. Signs Licensing Agreement with Level Brands Inc. and Its Chairman Emeritus And Chief Brand Strategist Kathy Ireland

Isodiol International Inc., (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F)(the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has entered into a licensing agreement with Level Brands Inc. (NYSE American:LEVB), an innovative marketing and licensing company that provides bold, unconventional and socially

New to the Investing News Network

Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping you identify investment opportunities in niche markets, and helping leading companies communicate their value to investors.

Revive Therapeutics Announces Update on its Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis…

Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid-based pharmaceutical markets, today announced an update on the Company’s collaboration agreement with Chemi Pharmaceutical Inc. (“Chemi Pharma”), a Licensed Dealer for

10+ Gold Stocks to Watch

Stocks.
Expert Insights.
Industry Stats.


Give me my free report!
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Big News Roundup: Telferscot and Canntab Therapeutics Execute Definitive Agreement; Phivida Launches Nano-CBD™ Iced Tea Product Line

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/big-news-roundup-lifescience/